308265.fig.002
Figure 2: GITR function in antitumoral immunity. Treatment with anti-GITR antibody and GITRL recombinant protein induces activation of CD8+ cells through upregulation of GITR, release of IFN- 𝛾   and Granzyme B. There is evidence that some tumors express GITRL.